This caused the quick pop- Sequenom's CMM "on the brink of a growth spurt," GenomeWeb reports Feb 18 Sequenom (SQNM) is "on the very of a recovery," according to a spokesperson, who also noted that the company's Center for Molecular Medicine, or CMM, is "on the brink of a growth spurt." The company recently launched its SensiGene fetal sex-determination test and the SensiGene fetal RHD genotyping test, which the company hopes will be adopted across the OB-GYN community. The lab currently employs about 20 people, but "more will be needed if the new line-up of blood tests take off."
A report of suspicious call buying. http://www.marketintellisearch.com/articles/1002883.html Earnings Whispers said earnings supposed to be last night. Maybe BlackRock wants the whole thing. In any case, the call buying continues while the company is mum.
Call buyer again in front month options. Get "lucky" on new data to be released at the New Zealand conference this week.
it'll be a blowoff tomm. on earnings.........they will have done the deed. go ahead and buy those $5 calls and we'll talk later. diazapam............
Look out below in this pig. I guess we're going hear about the longs who "just got lucky and covered" now that its tanked.